FDA approves new treatment to reduce the risk of breast cancer returning [Archive]

View Full Version : FDA approves new treatment to reduce the risk of breast cancer returning

News

07-18-2017, 07:24 AM

The U.S. Food and Drug Administration has approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer.

More... (http://www.medicalnewstoday.com/releases/318481.php)